Author(s): Koehn FE, Carter GT
Natural products and their derivatives have historically been invaluable as a source of therapeutic agents. However, in the past decade, research into natural products in the pharmaceutical industry has declined, owing to issues such as the lack of compatibility of traditional natural-product extract libraries with high-throughput screening. However, as discussed in this review, recent technological advances that help to address these issues, coupled with unrealized expectations from current lead-generation strategies, have led to a renewed interest in natural products in drug discovery.
Referred From: https://www.nature.com/nrd/journal/v4/n3/abs/nrd1657.html
Author(s): Newman DJ, Cragg GM, Snader KM
Author(s): Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et al.
Author(s): Zuo YG, Meng FY, Hao XY, Zhang YL, Wang GC, et al.
Author(s): Cushnie TPT, Lamb AJ
Author(s): Avato P, Bucci R, Tava A, Vitali C, Rosato A, et al.
Author(s): Taleb-Contini SH, Salvador MJ, Watanabe E
Author(s): Abu-Shanab BG, Adwn D, Safiya A, Jarrar N, Adwan K
Author(s): Maiti A, Dewanjee S, Mandal SC
Author(s): Shoba FG, Thomas M
Author(s): Niezen JH, Waghorn GC, Charleston
Author(s): Athnosiadou S, Kyriazakis I, Jackson F, Coop RL
Author(s): Thompson DP, Geary TG